Copyright
©The Author(s) 2025.
World J Gastroenterol. Mar 21, 2025; 31(11): 104377
Published online Mar 21, 2025. doi: 10.3748/wjg.v31.i11.104377
Published online Mar 21, 2025. doi: 10.3748/wjg.v31.i11.104377
Table 1 Baseline characteristics of patients with positive and negative pathologic upgrade, n (%)
Group | Negative (n = 78) | Positive (n = 93) | Statistics | P value | |
General characteristics | Sex, male/female | 47/31 | 74/19 | 7.648 | 0.006 |
Age, years | 59.33 ± 12.45 | 61.85 ± 9.90 | -1.44 | 0.151 | |
BMI, kg/m2 | 23.2 [21.6, 25.2] | 24.4 [22.7, 25.9] | 3040.5 | 0.069 | |
Smoker | 22 (28.21) | 37 (39.78) | 2.517 | 0.113 | |
Alcohol drinker | 28 (35.90) | 35 (37.63) | 0.055 | 0.815 | |
13C+ | 8 (10.26) | 8 (8.60) | 0.214 | 0.644 | |
Taking aspirin | 4 (5.13) | 5 (5.38) | < 0.001 | 1 | |
CEA, μg/L | 1.64 [1.20, 2.89] | 2.23 [1.58, 3.02] | 2732.5 | 0.025 | |
CA199, U/mL | 8.25 [5.05, 11.58] | 9.44 [5.79, 13.98] | 3011 | 0.179 | |
AFP, μg/L | 2.72 [2.16, 3.80] | 2.58 [1.92, 3.54] | 3683.5 | 0.169 | |
CA125, U/mL | 9.40 [7.63, 10.80] | 9.03 [6.74, 12.95] | 2395.5 | 0.936 | |
White light endoscopy characteristics | Size | 1.85 ± 1.16 | 2.52 ± 1.37 | 15.448 | < 0.001 |
Location | 1.801 | 0.772 | |||
Cardia | 5 (6.41) | 9 (9.68) | |||
Fundus | 1 (1.28) | 2 (2.15) | |||
Corpus | 10 (12.82) | 16 (17.20) | |||
Horns | 18 (23.08) | 21 (22.58) | |||
Antrum | 44 (56.41) | 45 (48.39) | |||
Atrophy | 21 (26.29) | 43 (46.24) | 6.757 | 0.009 | |
Biopsy cores | 2.0 (1.0,3.0) | 2.0 (1.0,3.0) | 3499.000 | 0.678 | |
White coating | 11 (14.10) | 28 (30.11) | 6.172 | 0.013 | |
Ulceration | 1 (1.28) | 12 (12.90) | 8.156 | 0.004 | |
Erosion | 37 (47.44) | 52 (55.91) | 1.222 | 0.269 | |
Congested lesion | 41 (52.56) | 59 (63.44) | 2.067 | 0.151 | |
Bleeding | 5 (6.41) | 11 (11.83) | 1.468 | 0.226 | |
Paris classification | 0.663 | 0.416 | |||
I/III | 7 (8.97) | 12 (12.90) | |||
II | 71 (91.03) | 81 (87.10) | |||
Surface roughness | 43 (55.13) | 59 (63.44) | 1.218 | 0.270 | |
Bile reflux | 8 (10.26) | 9 (9.68) | 0.016 | 0.900 | |
Biopsy pathology | Intestinal metaplasia | 44 (56.41) | 79 (84.95) | 17.109 | < 0.001 |
Atrophy | 7 (8.97) | 30 (32.26) | 13.563 | < 0.001 | |
Chronic inflammation | 78 (100.00) | 92 (98.92) | < 0.001 | 1 | |
Acute inflammation | 30 (38.46) | 39 (41.94) | 0.213 | 0.645 | |
HP in pathology | 10 (12.82) | 14 (15.05) | 0.175 | 0.675 | |
ME characteristics | ME | 76 (97.44) | 79 (84.95) | ||
Demarcation line | 54 (69.23) | 65 (69.89) | 2.738 | 0.098 | |
MV | 51.627 | < 0.001 | |||
Regular | 63 (80.77) | 20 (25.32) | |||
Irregular/absent | 13 (16.67) | 59 (74.68) | |||
MS | 11.115 | 0.001 | |||
Regular | 24 (31.58) | 7 (8.86) | |||
Irregular/absent | 52 (68.42) | 72 (91.14) | |||
White opaque substance | 17 (21.79) | 35 (37.63) | 8.36 | 0.004 | |
Light blue crest | 15 (19.23) | 38 (40.86) | 13.85 | < 0.001 | |
White globular appearance | 0 | 4 (4.30) | 3.95 | 0.047 |
- Citation: Lyu KM, Chen QQ, Xu YF, Yuan YQ, Wang JF, Wan J, Ling-Hu EQ. Development and validation of a predictive model for the pathological upgrading of gastric low-grade intraepithelial neoplasia. World J Gastroenterol 2025; 31(11): 104377
- URL: https://www.wjgnet.com/1007-9327/full/v31/i11/104377.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i11.104377